Gastric retention drug delivery system based on biomechanical response intelligent deformation and anchoring and preparation method thereof
The gastric retention drug delivery system, which utilizes biomechanically responsive intelligent deformation and anchoring, leverages thermally responsive shape memory polymers and microneedle structures to address the issues of short gastric retention time and easy drug degradation. This enables efficient and safe intragastric retention and release of drugs such as insulin, thereby improving bioavailability.
Patent Information
- Application Number
- CN202610064908.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-19
- Publication Date
- 2026-05-26
AI Technical Summary
Existing gastric retention drug delivery systems suffer from problems such as short retention time, easy drug degradation, low absorption efficiency, and inability to release drugs on demand. This is especially true for drugs with short half-lives, such as insulin, where bioavailability is extremely low and blood drug concentration fluctuates greatly.
A gastric drug delivery system based on biomechanical response intelligent deformation and anchoring is adopted. A biomimetic jellyfish body is constructed using thermally responsive shape memory polymer, combined with microneedle structure and controlled release unit. Long-term retention and intelligent release are achieved by body temperature-triggered shape change and mechanical locking force. The drug-loading unit is loaded with drugs by metal-organic framework carrier and released under triggering factors.
It achieves long-term retention in the stomach, intelligent release, and high bioavailability, avoiding mechanical damage to the stomach wall, and provides a safe and efficient drug delivery platform suitable for protein and peptide drugs, significantly improving the oral bioavailability of drugs.